| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOE
|
apolipoprotein E
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ATL1
|
atlastin GTPase 1
|
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1
|
|
AURKA
|
aurora kinase A
|
|
BCHE
|
butyrylcholinesterase
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD40LG
|
CD40 ligand
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD68
|
CD68 molecule
|
|
CDH13
|
cadherin 13
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CRYAA
|
crystallin, alpha A
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSTB
|
cystatin B (stefin B)
|
|
CTAG1A
|
cancer/testis antigen 1A
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEFT1P2
|
defensin, theta 1 pseudogene 2
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
DVL3
|
dishevelled segment polarity protein 3
|
|
EDN1
|
endothelin 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPHA2
|
EPH receptor A2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZR
|
ezrin
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FAM175A
|
family with sequence similarity 175, member A
|
|
FLG
|
filaggrin
|
|
FOXP3
|
forkhead box P3
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GBA
|
glucosidase, beta, acid
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GJC3
|
gap junction protein, gamma 3, 30.2kDa
|
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HBB
|
hemoglobin, beta
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HOXB13
|
homeobox B13
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL3
|
interleukin 3
|
|
IL33
|
interleukin 33
|
|
IRF6
|
interferon regulatory factor 6
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LTA
|
lymphotoxin alpha
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MC4R
|
melanocortin 4 receptor
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MIR143
|
microRNA 143
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR21
|
microRNA 21
|
|
MIR214
|
microRNA 214
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUTYH
|
mutY homolog
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NBN
|
nibrin
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NTF3
|
neurotrophin 3
|
|
NUCKS1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PFN1
|
profilin 1
|
|
PGR
|
progesterone receptor
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RARB
|
retinoic acid receptor, beta
|
|
RBBP5
|
retinoblastoma binding protein 5
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
SHH
|
sonic hedgehog
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
SYK
|
spleen tyrosine kinase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TGFA
|
transforming growth factor, alpha
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TRAPPC9
|
trafficking protein particle complex 9
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UTS2R
|
urotensin 2 receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VWF
|
von Willebrand factor
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WT1
|
Wilms tumor 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|